Salubrinal, a specific inhibitor of the PERK pathway, inhibits dengue-induced increase of calreticulin at 24 h post infection (HPI) but only barely reduces the high level of calreticulin induced by tunicamycin (Figure 1a). The gene discussed is EIF2AK3; the disease is dengue disease.